Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
2013 · Gut · 451 citations
https://doi.org/10.1136/gutjnl-2013-305279
C
Casper Steenholdt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
151
Papers
3.3K
Citations
31
h-index
51
i10-index
Casper Steenholdt is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 31, co-authored 129 publications.
ORCID: 0000-0003-3898-4212Papers by this author
worksComparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease
2013 · Therapeutic Drug Monitoring · 114 citations
https://doi.org/10.1097/ftd.0b013e31828d23c3
Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies
2016 · Inflammatory Bowel Diseases · 95 citations
https://doi.org/10.1097/mib.0000000000000772
Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials
2020 · EClinicalMedicine · 45 citations
https://doi.org/10.1016/j.eclinm.2020.100271
Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus
2013 · Scientific Reports · 42 citations
https://doi.org/10.1038/srep01110
Protocol for scoping review: Patient‐controlled sedation
2024 · Acta Anaesthesiologica Scandinavica · 2 citations
https://doi.org/10.1111/aas.14478
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat